Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience.
Jahan N, Taraba J, Boddicker NJ, Giridhar KV, Leon-Ferre RA, Tevaarwerk AJ, Cathcart-Rake E, O'Sullivan CC, Peethambaram PP, Hobday TJ, Mina LA, Batalini F, Advani P, Sideras K, Haddad TC, Ruddy KJ, Goetz MP, Couch FJ, Yadav S.
Jahan N, et al. Among authors: cathcart rake e.
Clin Breast Cancer. 2024 Oct 17:S1526-8209(24)00284-2. doi: 10.1016/j.clbc.2024.10.006. Online ahead of print.
Clin Breast Cancer. 2024.
PMID: 39516069